Delivery Order SPE2DB24D1021-SPE2DB25FFACP
- Not listed
- The Defense Logistics Agency Medical Supply Chain awarded a $2,922.80 delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Qsymia 3.75 mg-23 mg capsules in a 30-count package. This is a firm fixed-price delivery order with an ultimate completion date of August 12, 2025, and no set-aside designation was utilized. The award represents a competitive procurement action through an open competition process. AmerisourceBergen Drug Corp, headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a $1,013.42 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Qsymia 7.5 mg-46 mg capsules (30-count units). This is a non-set-aside, competitively awarded contract with an ultimate completion date of July 31, 2025, and performance to be fulfilled at the contractor's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded AmerisourceBergen Drug Corp a $1,945.44 firm fixed-price delivery order for QSYMIA 11.25 mg-69 mg capsules (30-count) on July 23, 2025, with completion targeted for July 24, 2025. This non-set-aside competitive award represents a single delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 through December 2026. The product...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of the pharmaceutical product Qsymia 7.5 mg-46 mg capsules. This $3,032.02 contract runs through April 4, 2024 and is not designated as a set-aside. AmerisourceBergen Drug Corp serves as a prime contractor to DLA, providing a wide range of pharmaceutical products and medical supplies to...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of QSYMIA 15 mg-92 mg capsules (30-count units) with a firm fixed price ceiling value of $1,643.28. This is a non-set-aside, competitively awarded contract with an ultimate completion date of July 22, 2025, and represents a child delivery order under AmerisourceBergen's larger contract vehicle. The place of performance is located in Conshohocken,...
- This delivery order, awarded on August 20, 2025, by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, provides for the supply of Qsymia 11.25 mg-69 mg capsules (30-count unit) with a firm fixed price ceiling value of $2,037.36. The order is scheduled for completion by August 21, 2025, and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. This award was not designated as a set-aside contract and was competitively awarded under an existing contract...
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,607.18 firm fixed-price contract is for the delivery of the prescription medication Qsymia 7.5 mg-46 mg capsules. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is the prime contractor and holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- The Defense Logistics Agency awarded a $938 delivery order to Amerisourcebergen Drug Corporation for Qsymia 7.5 mg-46 mg capsules. Under this firm fixed price contract, Amerisourcebergen will deliver 30 capsules of the specified weight-loss medication to a location in Conshohocken, Pennsylvania by July 12, 2023. The Defense Logistics Agency manages the Department of Defense's global logistics operations and works to support all military services and combatant commands. This small order for...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,234.40, is for the delivery of the prescription medication Qsymia 3.75 mg-23 mg capsules. The contract is a firm fixed-price delivery order, with a performance period ending on May 1, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a larger...
- The Defense Logistics Agency awarded a $256,720 firm fixed price delivery order to Amerisourcebergen Drug Corporation for Qsymia 3.75 MG-23 MG capsules. Under this order, Amerisourcebergen will deliver 30 capsules to a location in Conshohocken, Pennsylvania by August 17, 2023 to support the Defense Logistics Agency's medical supply needs. As a top 10 federal contractor, Amerisourcebergen regularly fulfills delivery orders for prescription drugs and other pharmaceutical products under DLA's Prime...
- SPE2DB24D1021Indefinite Delivery Contract
- SPE2DB24D1021-SPE2DB25FFACPDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,876.52 to AmerisourceBergen Drug Corp for the supply of Qsymia 7.5 mg-46 mg capsules (30-count units), a prescription medication used in weight management treatment. The contract, which was competitively awarded with no set-aside designation, was issued on August 28, 2025, with an ultimate completion date of August 29, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, utilizing firm fixed-price contract terms typical of the company's pharmaceutical supply arrangements with the federal government. This delivery order represents a task order against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive $999.999 billion pharmaceutical prime vendor agreement running through December 2026 that enables global medical supply support for military healthcare systems. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for the Defense Health Agency and other military medical supply chains, routinely fulfilling orders for brand-name and generic pharmaceuticals, vaccines, and medical devices across multiple therapeutic categories. The company's sustained contract performance and competitive awards reflect its capability to meet federal procurement requirements for diverse pharmaceutical products needed to support military and veteran healthcare operations worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 8/28/25 |